Skip to main content
Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · IEX Real-Time Price · USD
8.77
+0.55 (6.69%)
May 2, 2024, 11:38 AM EDT - Market open

Benitec Biopharma Revenue

Benitec Biopharma had revenue of $61.00K in the twelve months ending December 31, 2023, down -1.61% year-over-year. In the fiscal year ending June 30, 2023, Benitec Biopharma had annual revenue of $75.00K with 2.74% growth.

Revenue (ttm)
$61.00K
Revenue Growth
-1.61%
P/S Ratio
335.74
Revenue / Employee
$3,813
Employees
16
Market Cap
22.71M USD

Revenue Chart

* The company reports in AUD currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Jun 30, 202375.00K2.00K2.74%
Jun 30, 202273.00K14.00K23.73%
Jun 30, 202159.00K-43.00K-42.16%
Jun 30, 2020102.00K-12.10M-99.16%
Jun 30, 201912.20M9.09M291.99%
Jun 30, 20183.11M-4.44M-58.81%
Jun 30, 20177.56M4.73M167.39%
Jun 30, 20162.83M57.15K2.06%
Jun 30, 20152.77M2.35M564.21%
Jun 30, 2014416.81K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

BNTC News

More News